ES516902A0 - Un procedimiento para la preparacion de 4-(3-metil-2-butenil)-1,2-difenil-3,5-dioxopirazolidina. - Google Patents

Un procedimiento para la preparacion de 4-(3-metil-2-butenil)-1,2-difenil-3,5-dioxopirazolidina.

Info

Publication number
ES516902A0
ES516902A0 ES516902A ES516902A ES516902A0 ES 516902 A0 ES516902 A0 ES 516902A0 ES 516902 A ES516902 A ES 516902A ES 516902 A ES516902 A ES 516902A ES 516902 A0 ES516902 A0 ES 516902A0
Authority
ES
Spain
Prior art keywords
dioxopyrazolidine
butenyl
diphenyl
methyl
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516902A
Other languages
English (en)
Other versions
ES8308855A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto de Angeli SpA
Original Assignee
Instituto de Angeli SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Angeli SpA filed Critical Instituto de Angeli SpA
Publication of ES8308855A1 publication Critical patent/ES8308855A1/es
Publication of ES516902A0 publication Critical patent/ES516902A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms
    • C07D231/34Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES516902A 1981-10-29 1982-10-28 Un procedimiento para la preparacion de 4-(3-metil-2-butenil)-1,2-difenil-3,5-dioxopirazolidina. Granted ES516902A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24772/81A IT1168184B (it) 1981-10-29 1981-10-29 Processo per la preparazione della 4-(3-metil-2-butanile)-1,2-difenil-3,5 dichetopirazolidina

Publications (2)

Publication Number Publication Date
ES8308855A1 ES8308855A1 (es) 1983-10-01
ES516902A0 true ES516902A0 (es) 1983-10-01

Family

ID=11214682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516902A Granted ES516902A0 (es) 1981-10-29 1982-10-28 Un procedimiento para la preparacion de 4-(3-metil-2-butenil)-1,2-difenil-3,5-dioxopirazolidina.

Country Status (19)

Country Link
JP (1) JPS5888365A (es)
KR (1) KR840001955A (es)
AR (1) AR231832A1 (es)
AT (1) AT379151B (es)
CA (1) CA1179354A (es)
CH (1) CH651555A5 (es)
DK (1) DK477882A (es)
ES (1) ES516902A0 (es)
FI (1) FI823545L (es)
FR (1) FR2515646B1 (es)
GB (1) GB2108125B (es)
GR (1) GR77724B (es)
IT (1) IT1168184B (es)
NL (1) NL8204170A (es)
NO (1) NO823596L (es)
PH (1) PH19644A (es)
PT (1) PT75755B (es)
SE (1) SE8206143L (es)
YU (1) YU240282A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107778247A (zh) * 2016-08-30 2018-03-09 天津太平洋制药有限公司 一种非普拉宗及其中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1301857A (es) * 1969-06-27 1973-01-04

Also Published As

Publication number Publication date
NL8204170A (nl) 1983-05-16
GB2108125B (en) 1985-03-20
CH651555A5 (de) 1985-09-30
DK477882A (da) 1983-04-30
FR2515646B1 (fr) 1986-02-14
JPS5888365A (ja) 1983-05-26
SE8206143D0 (sv) 1982-10-28
ES8308855A1 (es) 1983-10-01
AR231832A1 (es) 1985-03-29
CA1179354A (en) 1984-12-11
GB2108125A (en) 1983-05-11
PT75755A (en) 1982-11-01
FR2515646A1 (fr) 1983-05-06
NO823596L (no) 1983-05-02
FI823545A0 (fi) 1982-10-18
IT8124772A0 (it) 1981-10-29
PH19644A (en) 1986-06-04
KR840001955A (ko) 1984-06-07
FI823545L (fi) 1983-04-30
AT379151B (de) 1985-11-25
SE8206143L (sv) 1983-04-30
PT75755B (en) 1985-11-20
YU240282A (en) 1985-03-20
GR77724B (es) 1984-09-25
IT1168184B (it) 1987-05-20
ATA370382A (de) 1985-04-15

Similar Documents

Publication Publication Date Title
ES518225A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES517222A0 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES516825A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES505922A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES510067A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoilurea.
ES511224A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina.
ES522386A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES515739A0 (es) Un procedimiento para la preparacion de derivados de fenilpiperidina sustituidos.
ES518305A0 (es) Un procedimiento para la preparacion de derivados de triazol.
ES504793A0 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
ES520631A0 (es) Un procedimiento para la preparacion de nuevos derivados de 5-hidroxi-3,4-dihidro-2h-benzopirano.
ES507482A0 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ES517002A0 (es) Un procedimiento para la preparacion de 1-(3-benciloxifenil)-1,1-dimetilheptano.
ES514263A0 (es) Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.
ES500870A0 (es) Un procedimiento para la preparacion de nuevos derivados de triariltiazol.
ES507045A0 (es) Un procedimientpo para la preparacion de nuevos derivados de carbamoiloxiisoxazol.
ES518545A0 (es) Un procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
ES514213A0 (es) Un procedimiento para la preparacion de nuevos derivados poliprenilicos.